Natixis’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.01M Buy
+73,829
New +$1.01M ﹤0.01% 723
2026
Q1
– Sell
-546,593
Closed -$3.92M – 1266
2025
Q4
$3.92M Buy
546,593
+546,536
+958,835% +$4.32M 0.01% 509
2025
Q3
$609 Buy
+57
New +$559 ﹤0.01% 1034
2024
Q2
– Sell
-1
Closed -$19 – 1107
2024
Q1
$19 Hold
1
– – ﹤0.01% 990
2023
Q4
$14 Sell
1
-13,106
-100% -$178K ﹤0.01% 1020
2023
Q3
$228K Buy
+13,107
New +$273K ﹤0.01% 700
2023
Q1
– Sell
-17,941
Closed -$501K – 1137
2022
Q4
$501K Buy
17,941
+752
+4% +$19.2K ﹤0.01% 716
2022
Q3
$403K Buy
17,189
+6,155
+56% +$186K ﹤0.01% 919
2022
Q2
$372K Buy
+11,034
New +$386K ﹤0.01% 973
2021
Q3
– Sell
-152,171
Closed -$4.6M – 1262
2021
Q2
$4.6M Buy
+152,171
New +$5.01M 0.02% 399

Other funds holding OGN

Natixis's OGN Position: Q3 2026 in Review

Natixis opened a new position in Organon & Co (OGN) in Q3 2026: 73,829 shares worth $1.01M. The stake represents ﹤0.01% of the portfolio and ranks #723 among its holdings. This is a return to the name: Natixis previously reported a position in OGN as recently as Q4 2025.

Natixis first reported a position in OGN in Q2 2021 and has held it in 10 quarters since. The position peaked at $4.6M in Q2 2021. 310 funds tracked by Wall St. Rank hold OGN as of Q3 2026.

  • Natixis held 73,829 shares of Organon & Co worth $1.01M as of Q3 2026.
  • Organon & Co was a new Natixis position in Q3 2026.
  • Organon & Co made up ﹤0.01% of Natixis's portfolio in Q3 2026, its #723 holding.
  • Natixis first reported a position in Organon & Co in Q2 2021 and has held it in 10 quarters since.
  • Natixis's Organon & Co position peaked at $4.6M in Q2 2021.
  • 310 funds tracked by Wall St. Rank held Organon & Co as of Q3 2026.

Based on Natixis's 13F filing for Q3 2026, filed 6 Nov 2026.